TC
HALO icon

TFS Capital’s Halozyme HALO Stock Holding History

TFS Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-33,809
Closed -$334K – 740
2016
Q4 		$334K Buy
+33,809
New +$370K 0.09% 383
2016
Q3 		– Sell
-16,286
Closed -$141K – 847
2016
Q2 		$141K Sell
16,286
-2,024
-11% -$20K 0.03% 808
2016
Q1 		$173K Buy
+18,310
New +$172K 0.02% 802
2015
Q4 		– Sell
-28,503
Closed -$383K – 801
2015
Q3 		$383K Buy
+28,503
New +$572K 0.04% 608
2015
Q2 		– Sell
-148,179
Closed -$2.12M – 981
2015
Q1 		$2.12M Buy
+148,179
New +$2.14M 0.21% 124
2014
Q4 		– Sell
-20,864
Closed -$190K – 1058
2014
Q3 		$190K Buy
+20,864
New +$199K 0.02% 880
2014
Q1 		– Sell
-27,247
Closed -$408K – 1441
2013
Q4 		$408K Sell
27,247
-119,169
-81% -$1.53M 0.02% 925
2013
Q3 		$1.62M Sell
146,416
-7,016
-5% -$58.5K 0.07% 397
2013
Q2 		$1.22M Buy
+153,432
New +$977K 0.05% 517

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

TFS Capital's HALO Position: Q1 2017 in Review

TFS Capital sold out of Halozyme (HALO) in Q1 2017, closing a stake of 33,809 shares — an estimated $334K sold.

TFS Capital first reported a position in HALO in Q2 2013 and held it in 9 quarters. The position peaked at $2.12M in Q1 2015. 160 funds tracked by Wall St. Rank hold HALO as of Q1 2017.

  • TFS Capital reported no remaining Halozyme position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 33,809 Halozyme shares in Q1 2017, an estimated $334K.
  • TFS Capital first reported a position in Halozyme in Q2 2013 and held it in 9 quarters.
  • TFS Capital's Halozyme position peaked at $2.12M in Q1 2015.
  • 160 funds tracked by Wall St. Rank held Halozyme as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.